Via rescue experiments, we have further proved that suppressing miR-125b-5p or increasing E2F3 expression levels sufficiently recovered POU6F2-AS2 depletion–induced anticarcinostatic activities in NSCLC. The gene discussed is POU6F2; the disease is non-small cell lung carcinoma.